Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series
Crossref DOI link: https://doi.org/10.1186/s40942-016-0028-9
Published Online: 2016-01-25
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Slean, Geraldine R.
Hemarat, Kornwipa
Khurana, Rahul N.
Stewart, Jay M.
Funding for this research was provided by:
Research to Prevent Blindness
That Man May See, Inc.